New strategy to help generate HIV-neutralising antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to recent research.
EXCLUSIVE: T-cell based vaccines against HIV
A new approach to HIV vaccines focuses on the importance of the T-cell sensitivity for the antigen, in this case, the HIV infected cell.
How HIV is assembled and released from infected cells
Researchers describe in detail how new virus particles assemble at the membrane of infected cells, and are released to attack healthy cells nearby.
EXCLUSIVE: The effects of alcohol drinking on antiretroviral therapy adherence
A recent study looked at the effects of drinking alcohol on adherence and showed the risk for non-adherence was double among drinkers compared to abstainers. We spoke to Christian Hendershot about his research.
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body’s immune response to HIV and HIV-infected cells, as well as to prostate cancer cells.
Looming financial pressures on world HIV/AIDS responses
Leading global health experts from around the world are showing that although HIV/AIDS challenges differ dramatically, rising to meet them could save millions of lives.